Related Experiment Video
Updated: Sep 13, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Update on desensitization to chemotherapeutics and biologicals
Joana Caiado1, Mariana C Castells2
1Immunoallergology Department, Unidade Local de Saúde Santa Maria, Hospital Santa Maria, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal.
None:
Hypersensitivity reactions to chemotherapeutics and biologicals are increasing, which can affect the prognosis of the underlying disease.
Purpose Of Review:
The goal of this review is to provide recent advancements in the diagnosis and management of hypersensitivity reactions based on current data.
Recent Findings:
Multiple studies have provided evidence of the safety and efficacy of rapid drug desensitizations. The knowledge of recently described phenotypes (type I, cytokine release syndrome, and mixed reactions) and current biomarkers (tryptase, interleukin-6, skin testing, basophil activation, and specific IgE) allows a correct risk stratification, critical to guide the desensitization planning. Personalized protocols and premedications have been successfully used to decrease the number and severity of breakthrough reactions.
Summary:
Rapid drug desensitization allows patients to be treated with best therapies, increasing the quality of life and life expectancy.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Desensitization and Tachyphylaxis
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
GPCR Desensitization
Effects of Chemicals: Overview
Allergic Drug Reactions
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists